drugset / Trial / NCT00403858

Movicol in Childhood Constipation (ProMotion Study)

NCT00403858

Phase 2 Completed 60 enrolled Norgine
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This was a single centre study comprised of two stages (Parts I and II). Part I was a 9-day open label evaluation of Movicol administered to patients in hospital. This study evaluated the safety and efficacy of Movicol in treating faecal impaction. Movicol was administered over 3 - 7 days to achieve disimpaction.

Timeline

Start
2000-10
Primary completion
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactulose Other / unclassified
Subject polyethylene glycol Other / unclassified 4 unknown Oral
Subject polyethylene glycol Other / unclassified 6 unknown Oral

Indications